Transform Wealth, LLC Candel Therapeutics, Inc. Transaction History
Transform Wealth, LLC
- $1.75 Billion
- Q4 2024
A detailed history of Transform Wealth, LLC transactions in Candel Therapeutics, Inc. stock. As of the latest transaction made, Transform Wealth, LLC holds 11,577 shares of CADL stock, worth $77,797. This represents 0.01% of its overall portfolio holdings.
Number of Shares
11,577Holding current value
$77,797% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding CADL
# of Institutions
58Shares Held
6.45MCall Options Held
112KPut Options Held
130K-
Northpond Ventures, LLC1.94MShares$13 Million48.35% of portfolio
-
Vanguard Group Inc Valley Forge, PA946KShares$6.36 Million0.0% of portfolio
-
Black Rock Inc. New York, NY823KShares$5.53 Million0.0% of portfolio
-
State Street Corp Boston, MA492KShares$3.31 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA449KShares$3.02 Million0.0% of portfolio
About Candel Therapeutics, Inc.
- Ticker CADL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,891,900
- Market Cap $194M
- Description
- Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the...